Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 31722-083

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 31722-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Lurasidone120mg30scountlabel (Lurasidone120mg30scountlabel)

Label for Lurasidone Hydrochloride Tablets 120 mg from Camber Pharmaceuticals, Inc. The label includes dosing information, storage instructions (20° to 25°C with excursions to 15° to 30°C), a medication guide notice, manufacturer details for Camber Pharmaceuticals and Annora Pharma Pvt. Ltd., and a 30-tablet count. The NDC number 31722-084-30 is also visible.*

FDA Label Image

Lurasidone20mg30scountlabel (Lurasidone20mg30scountlabel)

Label for Lurasidone Hydrochloride Tablets 20 mg by Camber Pharmaceuticals, Inc. The label indicates 30 film-coated tablets in the package, with dosing information noting each tablet contains 20 mg of lurasidone HCl. It includes storage instructions, a barcode, and manufacturer details including Annora Pharma Pvt. Ltd. in India.*

FDA Label Image

Lurasidone40mg30scountlabel (Lurasidone40mg30scountlabel)

Label for Lurasidone Hydrochloride Tablets 40 mg by Camber Pharmaceuticals, Inc. The label states each film-coated tablet contains 40 mg of lurasidone HCl. The package contains 30 tablets and includes a barcode, storage instructions (20° to 25°C with permitted excursions), and contact information for the manufacturer and medication guide details.*

FDA Label Image

Lurasidone60mg30scountlabel (Lurasidone60mg30scountlabel)

Label for Lurasidone Hydrochloride Tablets 60 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label states the NDC number 31722-082-30 and indicates a 30-tablet package. It includes storage instructions, a U.S. contact number, and manufacturing details from Annora Pharma Pvt. Ltd., India. A barcode and an unvarnished area are also visible.*

FDA Label Image

Lurasidone80mg30scountlabel (Lurasidone80mg30scountlabel)

Label for Lurasidone Hydrochloride Tablets 80 mg by Camber Pharmaceuticals, Inc. The label indicates a carton containing 30 film-coated oral tablets. It includes dosage strength, storage instructions, a barcode, and U.S. contact information for the manufacturer.*

FDA Label Image

Lurasidonehclfig1 (Lurasidonehclfig1)

A chart illustrating the fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of lurasidone when coadministered with various interacting drugs. Interacting drugs include strong and moderate CYP3A4 inhibitors and inducers such as ketoconazole, diltiazem, rifampin, and lithium, with changes plotted relative to lurasidone alone.*

FDA Label Image

Lurasidonehclfig2 (Lurasidonehclfig2)

A fold change chart with 90% confidence intervals showing pharmacokinetic interactions of various drugs. The X-axis represents change relative to interactive drug alone, ranging from -1.0 to 1.0. Listed interacting drugs include Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium with PK parameters such as Cmax, AUC, and Ctrough plotted.*

FDA Label Image

Lurasidonehclfig3 (Lurasidonehclfig3)

A chart displaying fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of Lurasidone Hydrochloride. The chart compares values across renal impairment categories (mild, moderate, severe), hepatic impairment categories (mild, moderate, severe), and population demographics including gender (females) and race (Asian, compared to Caucasian). The horizontal axis represents change relative to reference values.*

FDA Label Image

Lurasidonehclstructure. (Lurasidonehclstructure)

Chemical structure of Lurasidone Hydrochloride as depicted, showing its molecular arrangement including aromatic rings, nitrogen, sulfur, and oxygen atoms, alongside the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.